Literature DB >> 8941097

Prognostic value of exercise 201Tl tomography in patients treated with thrombolytic therapy during acute myocardial infarction.

H A Dakik1, J J Mahmarian, K T Kimball, M G Koutelou, R Medrano, M S Verani.   

Abstract

BACKGROUND: Although myocardial perfusion scintigraphy is of proven value in the risk stratification of patients with a recent myocardial infarction who receive conventional therapy, its value in patients undergoing thrombolytic therapy remains controversial. METHODS AND
RESULTS: Seventy-one patients who received thrombolytic therapy for acute myocardial infarction had exercise 201Tl tomography and coronary angiography before hospital discharge. Eleven (15%) of 71 patients had ischemic ST-segment depression during exercise, whereas 27 patients (38%) had scintigraphic ischemia. Twenty-five (37%) of 68 patients had a cardiac event consisting of either death (n = 2), recurrent myocardial infarction (n = 5), congestive heart failure (n = 7), or unstable angina (n = 11) during a follow-up of 26 +/- 18 months. Univariate predictors of cardiac events were as follows: Killip class (P = .04); left ventricular ejection fraction (P < .0005); total (P = .002) and ischemic (P < .0005) perfusion defect size; percent thallium lung uptake (P = .001); presence of infarct-zone redistribution (P = .02); and multivessel coronary artery disease (P = .01). By multivariate analysis, the significant joint predictors of risk were ejection fraction (P < .0005) and ischemic perfusion defect size (P = .005). The combination of ejection fraction and thallium tomography added significant incremental prognostic information to the clinical data, whereas angiography did not further improve a model that included clinical, ejection fraction, and tomographic variables.
CONCLUSIONS: Quantitative exercise 201Tl tomography provides important incremental, long-term prognostic information in patients receiving thrombolytic therapy for acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8941097     DOI: 10.1161/01.cir.94.11.2735

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  25 in total

1.  Proceedings of the 4th Invitational Wintergreen Conference. Wintergreen, Virginia, USA. July 12-14, 1998. Abstracts.

Authors: 
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

2.  Quantification of SPECT myocardial perfusion images: methodology and validation of the Yale-CQ method.

Authors:  Y H Liu; A J Sinusas; P DeMan; B L Zaret; F J Wackers
Journal:  J Nucl Cardiol       Date:  1999 Mar-Apr       Impact factor: 5.952

Review 3.  Role of nuclear cardiac imaging in myocardial infarction: postinfarction risk stratification.

Authors:  John J Mahmarian; Girish Dwivedi; Tultul Lahiri
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

Review 4.  Role of nuclear imaging after coronary revascularization.

Authors:  George L Adams; Srivani R Ambati; John M Adams; Salvador Borges-Neto
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

5.  Risk stratification after acute myocardial infarction: is it time to reassess? Implications from the INSPIRE trial.

Authors:  John J Mahmarian; Craig M Pratt
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

6.  Comparison of Tc-99m sestamibi SPECT with fractional flow reserve in patients with intermediate coronary artery stenoses.

Authors:  Marcus Hacker; Johannes Rieber; Rupert Schmid; Christian Lafougere; Andreas Tausig; Karl Theisen; Volker Klaus; Reinhold Tiling
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

7.  Combined assessment of left ventricular function and rest-redistribution regional myocardial thallium-201 activity for prognostic evaluation of patients with chronic coronary artery disease and left ventricular dysfunction.

Authors:  M Petretta; A Cuocolo; E Nicolai; W Acampa; M Salvatore; D Bonaduce
Journal:  J Nucl Cardiol       Date:  1998 Jul-Aug       Impact factor: 5.952

8.  Long-term prognostic value of early poststress (99m)Tc-tetrofosmin lung uptake during exercise (SPECT) myocardial perfusion imaging.

Authors:  Panagiotis Georgoulias; Ioannis Tsougos; Varvara Valotassiou; Chara Tzavara; Petros Xaplanteris; Nikolaos Demakopoulos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-17       Impact factor: 9.236

9.  Successful TRPV1 antagonist treatment for cardiac hypertrophy and heart failure in mice.

Authors:  Jaime S Horton; Cadie L Buckley; Alexander J Stokes
Journal:  Channels (Austin)       Date:  2012-12-06       Impact factor: 2.581

10.  Adenosine sestamibi SPECT post-infarction evaluation (INSPIRE) trial: A randomized, prospective multicenter trial evaluating the role of adenosine Tc-99m sestamibi SPECT for assessing risk and therapeutic outcomes in survivors of acute myocardial infarction.

Authors:  John J Mahmarian; Leslee J Shaw; Gerald H Olszewski; Bradley K Pounds; Maria E Frias; Craig M Pratt
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.